BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7547702)

  • 1. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition.
    Tate KM; Lee C; Edelman S; Carswell-Crumpton C; Liblau R; Jones PP
    Int Immunol; 1995 May; 7(5):747-61. PubMed ID: 7547702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
    Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
    J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.
    Pearson CI; Gautam AM; Rulifson IC; Liblau RS; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):197-202. PubMed ID: 9874795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of class II MHC allelic control of T cell responses.
    Racioppi L; Ronchese F; Schwartz RH; Germain RN
    J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
    Olson RR; De Magistris MT; Di Tommaso A; Karr RW
    J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell recognition of distinct peptide:I-Au conformers in murine experimental autoimmune encephalomyelitis.
    Huang JC; Han M; Minguela A; Pastor S; Qadri A; Ward ES
    J Immunol; 2003 Sep; 171(5):2467-77. PubMed ID: 12928395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism.
    Wu S; Gorski J
    Int Immunol; 1997 Oct; 9(10):1495-502. PubMed ID: 9352354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the allele specific Ag-binding site on murine class II MHC].
    Kajino K
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation to specific T cells by Ia molecules selectively altered by site-directed mutagenesis.
    Brett SJ; McKean D; York-Jolley J; Berzofsky JA
    Int Immunol; 1989; 1(2):130-40. PubMed ID: 2518656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residue 67 in the DRbeta1*0101 and DRbeta1*0103 chains strongly influences antigen presentation and DR-peptide molecular complex conformation.
    L'Faqihi FE; Praud C; Yassine-Diab B; Enault G; Lakhdar-Ghazal F; de Préval C; Coppin H
    Tissue Antigens; 1998 Jan; 51(1):10-9. PubMed ID: 9459499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A beta polymorphic residues responsible for class II molecule recognition by alloreactive T cells.
    Buerstedde JM; Nilson AE; Chase CG; Bell MP; Beck BN; Pease LR; McKean DJ
    J Exp Med; 1989 May; 169(5):1645-54. PubMed ID: 2469762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.